In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA) closed at $17.10 in the last session, up 0.35% from day before closing price of $17.04. In other words, the price has increased by $0.35 from its previous closing price. On the day, 0.96 million shares were traded. CNTA stock price reached its highest trading level at $18.215 during the session, while it also had its lowest trading level at $16.82.
Ratios:
We take a closer look at CNTA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 21.52 and its Current Ratio is at 21.52. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.17.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on September 20, 2024, Upgraded its rating to Overweight and sets its target price to $26 from $11 previously.
On September 19, 2024, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $33.
On July 18, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $14.Oppenheimer initiated its Outperform rating on July 18, 2024, with a $14 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 25 ’24 when Weinhoff Gregory M bought 10,000 shares for $17.39 per share.
SAHA SAURABH bought 299 shares of CNTA for $10,451 on Nov 25 ’24. On Nov 20 ’24, another insider, SAHA SAURABH, who serves as the Chief Executive Officer of the company, sold 55,000 shares for $16.89 each. As a result, the insider received 928,719 and left with 575,661 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNTA now has a Market Capitalization of 2254549504 and an Enterprise Value of 1545192704. For the stock, the TTM Price-to-Sale (P/S) ratio is 325.82 while its Price-to-Book (P/B) ratio in mrq is 4.51. Its current Enterprise Value per Revenue stands at 225.477 whereas that against EBITDA is -9.58.
Stock Price History:
Over the past 52 weeks, CNTA has reached a high of $18.74, while it has fallen to a 52-week low of $5.58. The 50-Day Moving Average of the stock is 6.18%, while the 200-Day Moving Average is calculated to be 43.21%.
Shares Statistics:
According to the various share statistics, CNTA traded on average about 669.22K shares per day over the past 3-months and 874340 shares per day over the past 10 days. A total of 98.77M shares are outstanding, with a floating share count of 89.08M. Insiders hold about 32.34% of the company’s shares, while institutions hold 51.12% stake in the company. Shares short for CNTA as of 1730332800 were 2147348 with a Short Ratio of 3.21, compared to 1727654400 on 1956095. Therefore, it implies a Short% of Shares Outstanding of 2147348 and a Short% of Float of 2.0599999.
